`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`Apotex, Inc.,
`
`Petitioner,
`
`v.
`
`UCB BIOPHARMA SPRL
`
`Patent Owner.
`______________
`
`Case IPR2019-00400
`U.S. Patent No. 8,633,194
`Title: Pharmaceutical composition of piperazine derivatives
`______________
`
`
`PATENT OWNER POWER OF ATTORNEY
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`IPR2019-00400
`Patent 8,633,194 B2
`
`
`
`
`PATENT OWNER POWER OF ATTORNEY
`
`Patent Owner, UCB Biopharma Sprl, hereby appoints the following as its
`
`attorneys to transact all business in the United States Patent & Trademark Office
`
`associated with the above-captioned inter partes review:
`
`James S. Trainor (Reg. No. 52,297), having a postal, email, and hand-
`
`delivery address of:
`
`James S. Trainor, Reg. No. 52,297
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, New York 10010
`Telephone: (212) 921-2001
`jtrainor@fenwick.com
`
`Robert E. Counihan (Reg. No. 61,382), having a postal, email, and hand-
`
`delivery address of:
`
`Robert E. Counihan, Reg. No. 61,382
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, New York 10010
`Telephone: (212) 921-2001
`rcounihan@fenwick.com
`
`Erica R. Sutter (Reg. No. 77,450), having a postal, email, and hand-delivery
`
`address of:
`
`Erica R. Sutter, Reg. No. 77,450
`Fenwick & West LLP
`801 California Street
`Mountain View, California 94041
`
`2
`
`
`
`
`
`IPR2019-00400
`Patent 8,633,194 B2
`
`
`Telephone: (650) 988-8500
`esutter@fenwick.com
`and all other practitioners working in conjunction with the aforementioned
`
`attorneys.
`
`The individual signing below has the authority to execute this document on
`
`behalf of UCB Biopharma Sprl.
`
`/Stéphane Drouin/
`(Electronically signed)
`[SIGNATURE]
`
`Stéphane Drouin
`[BY]
`
`Chief IP Counsel
`[TITLE]
`
`January 3, 2019
`[DATE]
`
`
`
`
`
`
`
`
`3
`
`